Download The How to of placing offenders at a Meth Treatment Center:

The “How to” of placing offenders at a Meth Treatment Center:
How do I place, or recommend a revoked probationer to be placed at a Meth Treatment
Center?
In order to have a revoked probationer placed at a Meth treatment facility, the
probation officer must file a report of violation with the court and county attorney.
The report of violation should be based on actions of the probationer that fit into
one or more of the Meth treatment center referral criteria categories 2, 3 or 4
(Located on pages 4-6). If the court finds that the probationer is in violation, the
court can do one of the following:
1. Revoke a portion of the suspended sentence, say 24 months, and commit the
person to the Department of Corrections for that period. During this time, the
person would be placed at the Meth treatment center and expected to
successfully complete the program. The balance of the sentence would be
suspended and the offender would serve it on probation. Even if the offender
originally received a commitment to prison, district court judges have the
authority to transfer the offender from a prison commit to a DOC commit,
pursuant to §46-18-203(7)(a)(iii), provided that the sentence does not impose
a longer imprisonment or commitment than the original sentence.
2. Revoke the offender’s suspended sentence and commit the offender to the
Department of Corrections. The DOC will then have the authority to place the
individual in an appropriate program or facility, such as the Meth treatment.
If the individual placed at the Meth treatment program and successfully
completes the program, then the DOC would have the discretion to
conditionally release the person to community supervision. Similar to #2, a
judge may convert a prison commitment to a DOC commitment, provided the
judge does not impose a longer sentence of imprisonment than the original
sentence.
Draft 4/26/07 ACCD
1
How do I place, or recommend an offender on Conditional Release to be placed at a
Meth Treatment Center?
Similar to probationers, the conditional releasee who will be considered for
placement at a Meth treatment facility is one who is in violation, based on actions
of the conditional releasee that fits into one or more of the Meth treatment center
referral criteria categories 2, 3 or 4. In this case, the probation officer should
proceed to revoke the offender’s conditional release status by filing a statement of
charges/notice of disciplinary hearing. The probation bureau should use the same
process that is used for revoking conditional release and sending them back to
prison. Instead, the conditional release offender will go to the Meth treatment.
The offender who is revoked from conditional release and sent to Meth treatment
must receive all the same due process protections as an offender being sent to
prison.
How do I place or recommend an offender who is a Parolee to be placed at a Meth
Treatment Center?
For a parolee who will be considered for placement at a Meth treatment facility is
one who is in violation, based on actions of the parolee that fits into one or more
of the Meth treatment center referral criteria categories 2, 3 or 4. The Board of
Pardon and Parole, at their discretion, may recommend disposition of the parole
violator to the Meth treatment center or recommend the parole violator returns to
prison. The probation bureau should use the same process that is used for
revoking parole violators to START.
How do I place or recommend an offender who is a Prison Inmate to be placed at a
Meth Treatment Center?
Prison Inmates who’s previous criminal activity and/or lifestyle that fits into one
or more of the Meth treatment center referral criteria categories 2, 3 or 4 and at
the discretion of the Board of Pardon and Parole have a disposition indicating
parole upon successful completion of the Meth treatment program, including the 6
months aftercare at a prerelease or have a disposition of a parole hearing while at
the prerelease center. Inmates who have been identified by IPPOs and/or inhouse screening committees and are within 16 to 18 months of Parole eligibility
can be considered for placement at a Meth treatment facility.
Draft 4/26/07 ACCD
2
There is one important caveat to these options – not all offenders will be screened and
accepted by the Meth treatment programs, just like all other Community Correction
programs. The Meth treatment centers are responsible for screening all offenders who
apply for admission to the program, and the programs have the discretion to accept or
deny admission. Because admission is dependant on an offender’s circumstances,
including criminal history, there is no guarantee that every offender will be accepted into
the programs. (See A.R.M. 20.7.913)
For purposes of placement at a Meth treatment facility, successful completion of the
Meth treatment program, means a 9 month successful stay at the Meth treatment center
and 6 months successful stay at an aftercare program at a prerelease center.
Draft 4/26/07 ACCD
3
Meth Treatment Center Referral Criteria:
2. Chronic Methamphetamine Abuse
Abuse is defined as: A maladaptive pattern of substance use leading to clinically
significant impairment or distress, as manifested by one (or more) of the following,
occurring within a 12-month period:
1. recurrent substance use resulting in a failure to fulfill major role obligations at
work, school, or home (e.g., repeated absences or poor work performance related
to substance use, substance-related absences, suspensions, or expulsions from
school; neglect of children or household)
2. recurrent substance use in situations in which it is physically hazardous (e.g.,
driving an automobile or operating a machine when impaired by substance use)
3. recurrent substance-related legal problems (e.g., arrests for substance related
disorderly conduct).
4. continued substance use despite having persistent or recurrent social or
interpersonal problems caused or exacerbated by the effects of the substance
(e.g., arguments with spouse about the consequences of intoxication, physical
fights).
A. The symptoms have never met the criteria for Substance Dependence for
this class of substance.
Referral Criteria:
Offenders sentenced to DOC for any offense, but have continued to use
methamphetamine while on supervision and have had one or more failed opportunities
for treatment in the community. Recommendations from LAC, LCPC or other
community based addiction specialists, based on a CD evaluation completed in the
previous 6 months may be used for referral to treatment programs.
Draft 4/26/07 ACCD
4
3. Stimulant Use Disorder – abuse of other amphetamines or cocaine.
Dependence defined as:
A maladaptive pattern of substance use, leading to clinically significant
impairment or distress, as manifested by three or more of the following,
occurring at any time in the same 12-month period:
1. Tolerance, as defined by either of the following:
a. a need for markedly increased amounts of the substance to achieve
intoxication or the desired effect
b. markedly diminished effect with continued use of the same amount
of the substance.
2. withdrawal, as manifested by either of the following:
a. the characteristic withdrawal syndrome for the substance
b. the same (or closely related substance) is taken to relieve or avoid
withdrawal symptoms.
3. the substance is often taken in larger amounts or over a longer period than
was intended.
4. there is a persistent desire or unsuccessful efforts to cut down or control
substance use
5. a great deal of time is spent in activities necessary to obtain the substance
(e.g. visiting multiple doctors or driving long distances), use the substance
(e.g.. chain-smoking), or recover from its effects
6. important social, occupational, or recreational activities are given up or
reduced because of substance use
7. the substance use is continued despite knowledge of having a persistent or
recurrent physical or psychological problem that is likely to have been
caused or exacerbated by the substance (e.g. current cocaine use despite
recognition of cocaine-induced depression, or continued drinking despite
recognition that an ulcer was made worse by alcohol consumption).
Referral criteria:
Offenders sentenced to DOC who continue to abuse prescription amphetamines and/or
purchase prescription amphetamines from others, use cocaine or excessive use of nonprescription stimulants. Offenders with a prior diagnosis of methamphetamine
dependence or abuse who continue to use other stimulants. Offenders, who have had one
or more interventions on supervision, continue to use and have not/will not participate in
treatment in the community. Recommendations from LAC, LCPC or other community
based addiction specialists, based on a CD evaluation completed in the previous 6 months
may be used for referral to treatment programs.
Draft 4/26/07 ACCD
5
3.
Co-occurring Disorders
Referral Criteria:
Offenders sentenced to DOC who have a history of Polysubstance Dependence or Abuse
and a co-occurring mental health diagnosis. Offenders who violate conditions of
supervision by using any substance to self-medicate symptoms of mental illness or those
who discontinue prescribed medications for symptoms of mental illness and then
continually relapse on alcohol, illegal drugs, or other prescription drugs obtained
illegally. Offenders, who have had failed opportunities to complete treatment in the
community. Recommendations from LAC, LCPC or other community based addiction
specialists, based on a CD evaluation completed in the previous 6 months may be used
for referral to treatment programs.
Definitions (2, 3 and 4) and referral criteria developed by Sue Orand, Treatment
Manager, Montana Women’s Prison, using DSM-IV Diagnostic Criteria for abuse and
dependency.
Draft 4/26/07 ACCD
6
Meth Treatment Glossary of Terms:
Abstinence:
Non-use of a specific substance. In recovery, non-use of any addictive psychoactive
substance. May also denote cessation of an addictive behavior, such as gambling, over
eating, etc.
Addiction:
A primary, chronic, neurobiologic disease, with genetic, psychosocial and environmental
factors influencing its development and manifestations. It is characterized by behaviors
that include one or more of the following: impaired control over drug use, compulsive
use, continued use despite harm, and craving.
Co-Occurring Disorders:
Concurrent substance-related and mental disorders. Other terms used to describe cooccurring disorders include “dual diagnosis,” “dual disorders,” “ mentally ill chemically
addicted” (MICA), “chemically addicted mentally ill” (CAMI), “mentally ill substance
abusers” (MISA), “mentally ill chemically dependent” (MICD), “coexisting disorders,”
“cormorbid disorders,” and “individuals with co-occurring psychiatric and substance
symptomatology” (ICOPSS). Use of the term carries no implication as to which disorder
is primary and which is secondary, which disorder occurred first, or whether one disorder
caused the other.
Continuum of Care:
An integrated network of treatment services and modalities, designed so that an
offender’s changing needs will be met as that offender moves through the treatment and
recovery process.
Dependence:
Used in three different ways: (1) physical dependence is a state of adaptation that is
manifested by a drug class specific withdrawal syndrome that can be produces by abrupt
cessation, rapid dose reduction, decreasing blood level of the drug, and/or administration
of an antagonist; (2) psychological dependence is a subjective sense of need for a specific
psychoactive substance, either for its positive effects or to avoid negative effects
associated with its abstinence; and (3) one category of psychoactive substance abuse use
disorder.
Draft 4/26/07 ACCD
7
Failure (as in Treatment failure):
Lack of progress and/or regression at any given level of care. Such a situation warrants a
reassessment of the treatment plan, with modification of the treatment approach. Such
situations may require changes in the treatment plan at the same level of care or transfer
to a different (more or less intensive) level of care to achieve a better therapeutic
response. Sometimes used to describe relapse after a single treatment episode—an
inappropriate construct in describing a chronic disease or disorder.
Length of Stay*:
Meth Treatment programs are 9 month (270 days) length of stay, followed by a 6 month
(180 day) aftercare in a Prerelease Center, for a 15 month continuum of care. Length of
stay’s beyond the 270 days in Meth Treatment require a written approval from the
Treatment Contract Program Manager and length of stay’s beyond the 180 days in
Prerelease require a written approval from the Prerelease Contract Manager.
Polysubstance Dependence:
A DSM-IV diagnosis (304.80) reserved for behavior during the same 12-month period in
which the individual was repeatedly abusing at least three groups of substances
(excluding caffeine and nicotine), but no single substance predominated. Such use met
the dependence criteria for substances as a group, but not for any specific substance.
Definitions based on ASAM Patient Placement Criteria for the Treatment of SubstanceRelated Disorders, Second Edition-Revised.
* - Length of Stay definition: ACCD/DOC Policy
Draft 4/26/07 ACCD
8